EVN

EVN Therapeutics is a biotechnology company focused on the development of novel small molecule therapies that target microtubule dynamics. The company's primary research efforts are directed toward creating treatments for various forms of cancer and neurodegenerative diseases where microtubule stability plays a critical role. By leveraging its expertise in microtubule-targeting agents, EVN aims to develop drugs with improved efficacy and reduced toxicity compared to traditional tubulin-binding agents. The company is currently in the pre-clinical stage, advancing its lead candidates through rigorous testing to establish proof-of-concept for clinical entry.